CoreCap Advisors’s abrdn Healthcare Opportunities Fund THQ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$208K Buy
+11,087
New +$202K 0.01% 851
2026
Q1
Sell
-12,667
Closed -$242K 3061
2025
Q4
$242K Buy
12,667
+11,917
+1,589% +$219K 0.01% 728
2025
Q3
$13K Buy
+750
New +$12.8K ﹤0.01% 1828
2025
Q2
Sell
-4,300
Closed -$88.8K 3224
2025
Q1
$88.8K Buy
4,300
+3,300
+330% +$67.4K ﹤0.01% 948
2024
Q4
$18.9K Sell
1,000
-1,800
-64% -$37.2K ﹤0.01% 1556
2024
Q3
$61.8K Buy
+2,800
New +$59.9K ﹤0.01% 1110
2022
Q4
$4.95K Buy
+250
New +$4.93K ﹤0.01% 1748
2022
Q3
Sell
-250
Closed -$5K 1934
2022
Q2
$5K Buy
+250
New +$5.23K ﹤0.01% 1691
2022
Q1
Sell
-250
Closed -$6K 1936
2021
Q4
$6K Buy
+250
New +$6.01K ﹤0.01% 1720

Other funds holding THQ

CoreCap Advisors's THQ Position: Q2 2026 in Review

CoreCap Advisors opened a new position in abrdn Healthcare Opportunities Fund (THQ) in Q2 2026: 11,087 shares worth $208K. The stake represents 0.01% of the portfolio and ranks #851 among its holdings. This is a return to the name: CoreCap Advisors previously reported a position in THQ as recently as Q4 2025.

CoreCap Advisors first reported a position in THQ in Q4 2021 and has held it in 9 quarters since. The position peaked at $242K in Q4 2025. 97 funds tracked by Wall St. Rank hold THQ as of Q2 2026.

  • CoreCap Advisors held 11,087 shares of abrdn Healthcare Opportunities Fund worth $208K as of Q2 2026.
  • abrdn Healthcare Opportunities Fund was a new CoreCap Advisors position in Q2 2026.
  • abrdn Healthcare Opportunities Fund made up 0.01% of CoreCap Advisors's portfolio in Q2 2026, its #851 holding.
  • CoreCap Advisors first reported a position in abrdn Healthcare Opportunities Fund in Q4 2021 and has held it in 9 quarters since.
  • CoreCap Advisors's abrdn Healthcare Opportunities Fund position peaked at $242K in Q4 2025.
  • 97 funds tracked by Wall St. Rank held abrdn Healthcare Opportunities Fund as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.